Aurinia Pharmaceuticals Inc.
DE ˙ DB ˙ CA05156V1022
13,91 € ↑0,53 (3,96%)
2026-06-04
AKTIENPREIS
SecurityDE:IKAP / Aurinia Pharmaceuticals Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,232,548 shares
Latest Disclosed Value $ 33,086,365
Morgan Stanley reports 0.71% increase in ownership of IKAP / Aurinia Pharmaceuticals Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 2,232,548 shares of Aurinia Pharmaceuticals Inc. (DE:IKAP) valued at $28,353,360 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 2,216,915 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of 0.71% during the quarter. The current value of the position is $31,054,743 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,232,548 15,633 0.71 33,086 -6.43 0.0020
2026-05-27 2025-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 2,216,915 270,130 13.88 35,360 64.38 0.0021
2026-02-13 2025-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,216,915 270,130 35,360 0.0021
2026-05-27 2025-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,946,785 -449,454 -18.76 21,512 5.99 0.0013
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,946,785 -449,454 21,512 0.0013
2025-08-15 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 2,396,239 28,477 1.20 20,296 6.62 0.0013
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,367,762 722,633 43.93 19,037 28.86 0.0014
2025-05-15 2024-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,645,129 174,632 11.88 14,773 37.07 0.0010
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,645,129 174,632 14,773 0.0010
2025-05-14 2024-09-30 13F/A-2 AURINIA PHARMACEUTICALS COM 05156V102 1,470,497 482,621 48.85 10,779 91.10 0.0008
2025-02-14 2024-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,470,497 482,621 10,779 0.0008
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,470,497 482,621 10,779 0.0008
2025-05-14 2024-06-30 13F/A-2 AURINIA PHARMACEUTICALS COM 05156V102 987,876 -316,262 -24.25 5,641 -13.67 0.0004
2024-10-17 2024-06-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 987,876 -316,262 5,641 0.0004
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 987,876 -316,262 5,641 0.0004
2024-10-17 2024-03-31 13F/A-2 AURINIA PHARMACEUTICALS COM 05156V102 1,304,138 -150,688 -10.36 6,534 -50.05 0.0005
2024-08-16 2024-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,304,138 -150,688 6,534 0.0001
2024-05-15 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,304,138 -150,688 6,534 0.0005
2024-08-16 2023-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,454,826 31,418 2.21 13,079 18.26 0.0012
2024-02-13 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,454,826 31,418 13,079 0.0012
2023-11-15 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,423,408 -262,378 -15.56 11,060 -32.23 0.0011
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,685,786 -188,643 -10.06 16,318 -20.57 0.0016
2023-05-15 2023-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,874,429 385,714 25.91 20,544 219.44 0.0022
2023-02-14 2022-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,488,715 21,686 1.48 6,431 -41.70 0.0007
2022-11-14 2022-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,467,029 -1,423,875 -49.25 11,031 -62.03 0.0015
2022-10-27 2022-06-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 2,890,904 -151,776 -4.99 29,054 -22.87 0.0038
2022-08-15 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 2,890,904 -151,776 29,054 0.0038
2022-10-27 2022-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 3,042,680 -1,708,039 -35.95 37,668 -65.33 0.0051
2022-05-13 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 3,042,680 -1,708,039 37,668 0.0051
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 4,750,719 -1,951,647 -29.12 108,648 -26.75 0.0134
2021-11-15 2021-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 6,702,366 3,080,674 85.06 148,323 216.01 0.0200
2021-08-23 2021-06-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 3,621,692 3,315,006 1,080.91 46,936 1,078.11 0.0062
2021-08-16 2021-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 3,627,287 3,320,601 47,009 0.0062
2021-05-17 2021-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 306,686 -505,638 -62.25 3,984 -64.54 0.0006
2021-02-16 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 812,324 687,500 550.78 11,234 510.88 0.0017
2020-11-13 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 124,824 30,329 32.10 1,839 19.73 0.0004
2020-08-14 2020-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 94,495 38,712 69.40 1,536 89.86 0.0003
2020-05-26 2020-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 55,783 -189,497 -77.26 809 -83.72 0.0002
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 55,783 -189,497 809 62.1481
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 245,280 220,854 904.18 4,970 3,693.89 0.0012
2019-11-14 2019-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 24,426 1,777 7.85 131 -12.08 0.0000
2019-08-14 2019-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 22,649 -10,145 -30.94 149 -30.37 0.0000
2019-05-15 2019-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 32,794 -54,534 -62.45 214 -64.03 0.0001
2019-02-14 2018-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 87,328 37,026 73.61 595 78.14 0.0002
2019-04-23 2018-09-30 13F/A-2 AURINIA PHARMACEUTICALS COM 05156V102 50,302 -25,837 -33.93 334 -22.14 0.0001
2018-11-20 2018-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 50,302 0 334 0.0001
2018-11-14 2018-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 50,302 -25,837 334
2019-04-23 2018-06-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 76,139 -531,222 -87.46 429 -86.39 0.0001
2018-08-14 2018-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 76,139 -531,222 429
2019-04-23 2018-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 607,361 239,172 64.96 3,151 88.91 0.0009
2018-05-14 2018-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 607,361 239,172 3,151
2019-04-23 2017-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 368,189 -203,363 -35.58 1,668 -53.47 0.0005
2018-02-14 2017-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 368,189 -203,363 1,668
2017-11-14 2017-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 571,552 8,259 1.47 3,585 3.82 0.0011
2017-08-11 2017-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 563,293 117,158 26.26 3,453 5.50 0.0010
2017-05-22 2017-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 446,135 442,138 11,061.75 3,273 40,812.50 0.0010
2017-05-12 2017-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 446,135 3,273
2017-02-22 2016-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 3,997 1,898 90.42 8 33.33 0.0000
2017-02-13 2016-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 3,997 8
2016-11-10 2016-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 2,099 0 0.00 6 0.00 0.0000
2016-08-12 2016-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 2,099 -56 -2.60 6 0.00 0.0000
2016-05-12 2016-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,155 1,100 104.27 6 200.00 0.0000
2016-02-09 2015-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,055 55 5.50 2 -33.33 0.0000
2016-02-08 2015-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,000 -55 -5.21 3 0.00 0.0000
2015-11-09 2015-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,000 3
2015-08-12 2015-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,055 1,002 1,890.57 3 0.00 0.0000
2015-05-14 2015-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 53 0 0.00 0 -100.00 0.0000
2015-02-13 2014-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 53 0 0.00 0 0.0000
2014-12-16 2014-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 53 53 0 0.0000
2014-11-14 2014-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 53 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.